Top

Current Infectious Disease Reports

Content (3 Articles)

Mpox Virus Skin, Soft Tissue, Bone and Joint Infections (N Safdar and A Haleem, Section Editors)

Monkeypox 2022 vs. COVID-19: a Review on a National Health Emergency with Emphasis on Cutaneous Manifestations

Mohammad Rezaei Zadeh Rukerd, Pouria Pourzand, Nasir Arefinia, Davood Bashash, Amin Sayyadi, Mohsen Nakhaie, Simin Shamsi Meymandi

Mpox Virus Tropical, Travel and Emerging Infections (LH Chen and F Norman, Section Editors)

Mpox in 2023: Current Epidemiology and Management

Sapha Barkati, Luke B. Harrison, Marina B. Klein, Francesca F. Norman

Dengue Virus Tropical, Travel and Emerging Infections (LH Chen and F Norman, Section Editors)

New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines

Sonia Menon, Annelies Wilder-Smith

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.